SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001200876-23-000013
Filing Date
2023-06-15
Accepted
2023-06-15 16:36:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3457
  Complete submission text file 0001200876-23-000013.txt   5195
Mailing Address 1 LIBERTY LANE E SUITE 100 HAMPTON NH 03842
Business Address 1 LIBERTY LANE E SUITE 100 HAMPTON NH 03842 603.929.2236
Novalis LifeSciences Investments I, L.P. (Reporting) CIK: 0001781605 (see all company filings)

IRS No.: 842004275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Subject) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39311 | Film No.: 231017926
SIC: 2834 Pharmaceutical Preparations